| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-35 |
Sentence |
denotes |
SARS-CoV-2, SARS-CoV, and MERS-COV: |
| T2 |
36-58 |
Sentence |
denotes |
A comparative overview |
| T3 |
59-207 |
Sentence |
denotes |
The recent outbreak of SARS-CoV-2 that started in Wuhan, China, has now spread to several other countries and is in its exponential phase of spread. |
| T4 |
208-322 |
Sentence |
denotes |
Although less pathogenic than SARS-CoV, it has taken several lives and taken down the economies of many countries. |
| T5 |
323-482 |
Sentence |
denotes |
Before this outbreak, the most recent coronavirus outbreaks were the SARS-CoV and the MERS-CoV outbreaks that happened in China and Saudi Arabia, respectively. |
| T6 |
483-592 |
Sentence |
denotes |
Since the SARS-CoV-2 belongs to the same family as of SARS-CoV and MERS-CoV, they share several similarities. |
| T7 |
593-766 |
Sentence |
denotes |
So, this review aims at understanding the new scenario of SARS-CoV-2 outbreak and compares the epidemiology, clinical presentations, and the genetics of these coronaviruses. |
| T8 |
767-971 |
Sentence |
denotes |
Studies reveal that SARS-CoV-2 is very similar in structure and pathogenicity with SARS-CoV, but the most important structural protein, i.e., the spike protein (S), is slightly different in these viruses. |
| T9 |
972-1165 |
Sentence |
denotes |
The presence of a furin-like cleavage site in SARS-CoV-2 facilitates the S protein priming and might increase the efficiency of the spread of SARS-CoV-2 as compared to other beta coronaviruses. |
| T10 |
1166-1244 |
Sentence |
denotes |
So, furin inhibitors can be targeted as potential drug therapies for SARS-CoV. |
